{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "NVEC",
  "name": "NVE Corporation",
  "url": "https://frontierpicks.com/dossiers/NVEC/",
  "json_url": "https://frontierpicks.com/dossiers/NVEC.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a3",
    "n": 3
  },
  "current_thesis": "One quarter re-rated the name — revenue +81% to $11.03M, gross margin 81.3% (2026-07-22) — and nothing has confirmed it since. No company datapoint arrives before the ~2026-10-21 Q2 print.",
  "invalidation_trigger": "A weekly close below $105 surrenders the 2026-07-23 gap shelf and ends the inflection leg; secondarily, Q2 FY2027 product sales (~2026-10-21 est.) printing under the $10.73M June-quarter level would recast that quarter as a pull-forward.",
  "catalyst_date": "2026-08-31",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "semiconductors-analog",
    "physical-ai-robotics",
    "medtech-diagnostics",
    "small-cap-value-rotation"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Fiscal year ends March 31 — \"Q1 FY2027\" is the quarter ended 2026-06-30. Third-party data sources label NVE's quarters inconsistently.",
    "4.84M shares outstanding (2026-08-08). Micro-float: realized single-session ranges are wide and quoted depth is thin.",
    "The company issues no formal revenue or EPS guidance and carries no meaningful sell-side coverage, so there is no consensus figure to beat or miss.",
    "The $1.00 quarterly dividend is declared by the board each quarter alongside results rather than under a stated payout policy.",
    "Peter G. Eames became President and CEO at the 2026-08-06 annual meeting; Daniel A. Baker moved to Chairman. The board expanded from five to seven directors.",
    "NVE reports quarterly results roughly three weeks after quarter-end, historically in late Jan, Apr, Jul and Oct."
  ],
  "body_markdown": "## Current Thesis\nThe leg being bought is still the same one: a step-change in spintronic sensor and coupler demand, evidenced by exactly one quarter. NVE reported the June quarter on 2026-07-22 — total revenue $11,034,057 versus $6.100M a year earlier, product sales $10,734,735 (97.3% of revenue), contract R&D revenue $299,322, gross margin 81.3%, diluted EPS $1.32 against $0.74 (10-Q filed 2026-07-22). The stock traded +52.4% to $132.07 intraday the next session (Benzinga, 2026-07-23).\n\nWhat has changed since early August is the absence of anything new and the direction of the flow. No NVEC-specific headline has appeared in the news feed since 2026-07-24. The 2026-08-21 close was $109.89, down 17.4% from the $133.06 52-week high, with RSI(14) at 36.6 and a three-month price change of +21.5%. Over the same window, then-CEO Daniel A. Leadership also turned over: Peter G. Eames became President and CEO at the 2026-08-06 annual meeting, with Baker moving to Chairman (announced 2026-06-22).\n\nThe narrative is **maturing**. The narrative works — the print was real and the trailing revenue line bent — but the attention burst was a single session of intraday-mover coverage on 2026-07-23, participation has thinned since 2026-07-24, and the only instrument that can extend or end it is the October print. Nothing between now and then produces new information.\n\n## Bull Case\n- Revenue for the quarter ended 2026-06-30 rose 81% to $11,034,057; product sales +82% to $10,734,735; contract R&D +53% to $299,322 (10-Q, 2026-07-22).\n- Gross margin 81.3% with operating margin 66% in the June quarter (Q1 FY2027 call, 2026-07-22). The FY2026 full-year comparison in the proxy was a 79% gross and 60% operating margin, so the June quarter expanded on both lines.\n- Net income $6,394,191, +79% YoY; diluted EPS $1.32 versus $0.74 (release, 2026-07-22).\n- Balance sheet carries the wait: cash $2,896,148 plus marketable securities $43,124,354, about 69% of total assets, against inventory of $6,673,227 (10-Q, quarter ended 2026-06-30). No debt-service pressure through a soft quarter.\n- Capital return held through the inflection — $1.00 per share declared 2026-07-22, payable 2026-08-31 to holders of record 2026-08-03, a $4.00 annualized rate.\n- Product vector with long qualification cycles: two wafer-level chip-scale sensors for implantable medical devices, roughly one-third the area of conventionally packaged parts and stable above 9 Tesla (call, 2026-07-22).\n- the board's automatic grants sit out of the money at the 2026-08-21 close of $109.89.\n\n## Bear Case\n- Insider flow ran the other way into strength. Twenty thousand shares sold by the then-CEO within five sessions of the print, at $114.08–$117.57, plus 1,500 more at $121.50 on 2026-08-17 — that is roughly a third of his direct common holding cleared inside three weeks of a +52.4% session.\n- Operating expenses rose 50% YoY on R&D staffing and performance-based compensation (10-Q). If revenue reverts toward the FY2026 quarterly average while the cost base stays, the 66% operating margin does not repeat.\n- The base rate remains hostile: FY2026 revenue $26.33M, +1.76% over FY2025's $25.87M (stockanalysis.com, 2026-08-08). One quarter has broken a two-year flat line and no second observation exists.\n- Management gave no revenue or EPS guidance and there is no meaningful sell-side estimate channel, so there is no consensus floor beneath the multiple and no analyst to mark the quarter against.\n- The 2026-07-23 gap remains unrepaired. That session printed $105.00 in pre-market before reaching $132.07; price at $109.89 now sits in the lower third of that range with RSI 36.6 and no base built.\n- CEO succession lands in the middle of the only inflection the company has had in three years. Eames took over on 2026-08-06 with no public quantitative framing of the demand step.\n- 4.84M shares outstanding (2026-08-08). Micro-float mechanics are symmetric; the same thinness that produced +52.4% in one session produces the drawdown on modest supply.\n\n## Setup & Price Structure\nReference close 2026-08-21: $109.89. 52-week high $133.06 (-17.4%). RSI(14) 36.6. Three-month price change +21.5%.\n\nThe structure is a single unrepaired gap. Pre-market on 2026-07-23 printed $105.00 (+21.1%) and the regular session reached $132.07; everything since has been a slide back through that range without filling it. Price is now below every insider sale price of the last month ($114.08 low, $121.50 high) and roughly 18% below the $129.43 strike on the 2026-08-06 director grants.\n\nCrowding and positioning observables, stated as observables:\n- Coverage clustered into two days — intraday-mover lists on 2026-07-23 and 2026-07-24 — then stopped. No company-specific headline in the feed since.\n- Insider distribution: 20,000 shares 2026-07-27→07-29, 1,500 shares 2026-08-17, both by the outgoing CEO.\n- No sell-side estimates, no institutional anchor; price discovery is flow-driven on a 4.84M-share count.\n- The dividend record date passed on 2026-08-03, so the yield-capture bid is out of the near-term tape ahead of the 2026-08-31 payment.\n- RSI 36.6 with the price mid-gap describes a name still giving back, not one that has based.\n\n$105 is the level that matters, because it marks where the 2026-07-23 pre-market gap opened. Above it, the post-print structure is intact and merely retracing. A weekly close below it means the entire re-rating session has been given back on no news.\n\n## Catalyst Calendar (next 30 days)\n- **2026-08-31** — $1.00 per share quarterly dividend payable; record date was 2026-08-03. Mechanical, cash out the door, no information content beyond the rate holding.\n- **No scheduled company event between 2026-08-31 and the Q2 report.** That absence is itself the near-term condition: for roughly seven weeks the name trades on flow and sector read-through only.\n- **~2026-10-21 (est.)** — Q2 FY2027 results, quarter ending 2026-09-30. Outside this 30-day window; NVE has historically reported about three weeks after quarter-end in late Jan, Apr, Jul and Oct.\n\n## What Would Change Our Mind\nThe October print is the binary and nothing resolves before it. Q2 FY2027 product sales materially below the $10,734,735 June-quarter level, or a sequential decline management attributes to order timing, recasts the June quarter as distributor pull-forward and removes the reason the multiple exists. The inverse holds: a second quarter at or above that level, with gross margin still near 81%, converts a single observation into a trend and makes the 2026-07-23 gap a floor rather than an overhang.\n\nOn price, a weekly close below $105 gives up the gap shelf and ends the inflection leg — that is the gradeable break. A slide to that level on no company news would also date the narrative's turn to saturated, since it would show the July bid was attention rather than a re-rating anyone is defending.\n\nTwo other things would flip the read. Continued insider selling by the new CEO or CFO before the October print, filed on Form 4, would say the people with the demand visibility are not treating $11M as a run-rate. And a gross margin print below 78%, or a company comment attributing mix shift to pricing, would mean Analog Devices, Allegro, Silicon Labs and Broadcom are pressing on the part of the P&L that makes the story work.\n\n## Correlation Notes\n- Analog and sensing complex — Analog Devices, Allegro MicroSystems, Infineon, Silicon Labs. Management framed the June quarter as occurring inside \"a strong semiconductor market\" (call, 2026-07-22); those peers' autumn guides on industrial and automotive bookings are the only third-party check on that claim before NVE reports.\n- Physical-AI/robotics basket. The robotics application language on the 2026-07-22 call is what earns NVE a second-order AI reading; sentiment there travels with the humanoid and industrial-automation names, not with NVE's own fundamentals.\n- Medtech device demand. Implantable-device sensor design wins tie the longer-cycle part of the revenue mix to cardiac and neuromodulation OEM programs, which do not correlate with semiconductor capex.\n- Micro-float behaviour dominates on any given day. With 4.84M shares outstanding, single-session moves are frequently unrelated to sector beta; index or sector comparisons explain little of the daily variance here.\n- Dividend-yield holders. A $4.00 annualized rate on a sub-$600M micro-cap attracts a distinct, price-insensitive holder base that behaves differently around record dates than the momentum flow that arrived on 2026-07-23.",
  "first_seen": "2026-08-07",
  "last_analyzed": "2026-08-22T09:44:19+00:00",
  "last_synthesized": "2026-08-22",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}